Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery

28 oktober 2026 uppdaterad av: Biyu Shen, Shanghai Jiao Tong University School of Medicine

Effects of Starry-Sky Projection and Maternal Voice on Postoperative Sleep in Children Undergoing Cardiac Surgery: A 2 × 2 Factorial Randomized Controlled Trial

The goal of this clinical trial is to determine whether a starry-sky projection affects sleep during the early period after cardiac surgery in young children. The main question it aims to answer is:

• Does a starry-sky projection improve how well children sleep during the first three nights after surgery compared with routine nighttime lighting? The study will also explore whether sleep outcomes differ between children who listen to their mother's recorded voice and those who listen to an unfamiliar woman's recorded voice, and whether the effect of the starry-sky projection differs depending on the type of voice.

Children aged 6 months to 6 years will be randomly assigned to one of four combinations of visual and sound conditions. They will:

  • Receive either a starry-sky projection or routine nighttime lighting
  • Listen to either their mother's recorded voice or an unfamiliar woman's recorded voice
  • Have their sleep monitored during the first three nights after surgery using a contactless device placed under the pillow that does not require sensors attached to the child.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Beräknad)

172

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200127
        • Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

6 månader till 6 år (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • A confirmed diagnosis of congenital heart disease.
  • Age between 6 months and 6 years.
  • Scheduled to undergo their first elective open-heart surgery.
  • An anticipated postoperative stay in the cardiac intensive care unit (CICU) of at least 48 hours.
  • Written informed consent provided by a parent or legal guardian.

Exclusion Criteria:

  • Epilepsy or another severe neurological disorder.
  • A severe psychiatric disorder.
  • Hearing impairment that interferes with the perception of auditory stimuli.
  • Visual impairment that interferes with the perception of visual stimuli.
  • Malformations of other organs or pre-existing severe comorbidities.
  • A history of chronic pain.
  • A previously diagnosed sleep disorder.
  • Endotracheal tube could not be successfully removed before 7 p.m. on the day of surgery.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Faktoriell uppgift
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Starry-Sky Projection + Maternal Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Experimentell: Starry-Sky Projection + Unfamiliar Female Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Aktiv komparator: Conventional Lighting + Maternal Voice

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Aktiv komparator: Conventional Lighting + Unfamiliar Female Voice

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Sleep Efficiency
Tidsram: Postoperative nights 0, 1, and 2

Sleep efficiency is defined as the percentage of total sleep time (TST) relative to time in bed (TIB) during the sleep-related nocturnal interval. TIB refers to the interval from the start of an attempt to sleep until the end of the nocturnal sleep opportunity and includes sleep onset latency and intervening wakefulness. Sleep efficiency will be assessed using a contactless ballistocardiography (BCG)-based sleep monitoring mat during postoperative nights 0-2. The mean sleep efficiency across the three postoperative nights will be used as the primary outcome measure. Higher values indicate better sleep efficiency.

Postoperative nights 0, 1, and 2

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Total Sleep Time
Tidsram: Postoperative nights 0, 1, and 2

Total sleep time during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep-Onset Latency
Tidsram: Postoperative nights 0, 1, and 2

Time from the beginning of the nocturnal sleep monitoring period to sleep onset, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Wake After Sleep Onset
Tidsram: Postoperative nights 0, 1, and 2

Total duration of wakefulness occurring after sleep onset during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep Fragmentation Index
Tidsram: Postoperative nights 0, 1, and 2

Sleep fragmentation index derived from the contactless sleep monitoring mat, reflecting the degree of sleep disruption during the nocturnal monitoring period.

Postoperative nights 0, 1, and 2
Sleep-Stage Distribution
Tidsram: Postoperative nights 0, 1, and 2

Estimated distribution of sleep stages during the nocturnal monitoring period, expressed as the proportion of total sleep time and measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Incidence of Postoperative Delirium
Tidsram: Postoperative night 0 through postoperative day 2

Postoperative delirium will be assessed using the Cornell Assessment of Pediatric Delirium (CAPD). A total CAPD score ≥9 will indicate a positive delirium screen. Assessments will be performed every 12 hours.

Postoperative night 0 through postoperative day 2
Richmond Agitation-Sedation Scale Score
Tidsram: Postoperative night 0 through postoperative day 2

Sedation and agitation will be assessed using the Richmond Agitation-Sedation Scale (RASS). Scores range from -5 to +4, with lower scores indicating deeper sedation and higher scores indicating greater agitation. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Pain Score
Tidsram: Postoperative night 0 through postoperative day 2

Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale. Scores range from 0 to 10, with higher scores indicating greater pain severity. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Postoperative Sedative Exposure
Tidsram: Postoperative day 0 through postoperative day 2

Administration of dexmedetomidine and other sedative medications will be recorded to characterize postoperative sedative exposure.

Postoperative day 0 through postoperative day 2
Postoperative Analgesic Exposure
Tidsram: Postoperative day 0 through postoperative day 2

Administration of sufentanil and other analgesic medications will be recorded to characterize postoperative analgesic exposure.

Postoperative day 0 through postoperative day 2
Postoperative Vasoactive Medication Exposure
Tidsram: Postoperative day 0 through postoperative day 2

Administration of dopamine and other vasoactive medications will be recorded to characterize postoperative vasoactive medication exposure.

Postoperative day 0 through postoperative day 2
Heart Rate Variability
Tidsram: Postoperative nights 0, 1, and 2

Heart rate variability will be continuously measured using the 5S Sleep Tracking Mat as an objective indicator of autonomic regulation.

Postoperative nights 0, 1, and 2
CICU Length of Stay
Tidsram: Measured in days admitted to the CICU, an average of 2 days

Cardiac intensive care unit (CICU) length of stay will be calculated from postoperative CICU admission to CICU discharge.

Measured in days admitted to the CICU, an average of 2 days
Total Hospital Length of Stay
Tidsram: Measured in days admitted to the hospital, an average of 10 days.

Total hospital length of stay will be calculated as the number of days from hospital admission to hospital discharge.

Measured in days admitted to the hospital, an average of 10 days.
Parental satisfaction
Tidsram: On the day of discharge, an average of 10 days

Parental satisfaction with the child's overall hospital care will be assessed using a 100-mm visual analogue scale (VAS), ranging from 0 mm ("very dissatisfied") to 100 mm ("very satisfied"). Higher scores indicate greater satisfaction.

On the day of discharge, an average of 10 days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 november 2026

Primärt slutförande (Beräknad)

31 mars 2027

Avslutad studie (Beräknad)

31 mars 2027

Studieregistreringsdatum

Först inskickad

22 september 2026

Först inskickad som uppfyllde QC-kriterierna

26 september 2026

Första postat (Faktisk)

2 oktober 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

30 oktober 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

28 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera